Mental-health startup Cerebral is laying off 15% of its workforce, or about 285 employees, as the company reels from a tumultuous year of public scrutiny and federal investigations into its prescribing practices.
CEO Dr. David Mou told employees in a February 27 email that the cuts are necessary for Cerebral to maintain a sustainable business “to ensure we can continue to provide care to our patients in need,” according to a copy seen by Insider.
In an email to Insider confirming the layoffs, a Cerebral spokesperson said the decision is the culmination of Cerebral’s efforts to reorganize the company to “refocus on the most important service offerings for our patients.”
It’s Cerebral’s third round of layoffs in less than a year. The company previously cut about 350 employees between June and July, according to Bloomberg News. It slashed an additional 20% of its workforce in October, the Wall Street Journal first reported, which Insider confirmed.
